This session provides an overview of new medicines available for cardiac conditions. Focus includes pharmacological treatment in adult and geriatric populations with cardiac disease such as heart failure, atrial fibrillation, and coronary disease.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 3/6/2023.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online NCPD evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Conferences Planning Committee Disclosures: No planning committee member discloses any actual or potential conflict of interest.
Speakers Conflict of Interest Disclosure: No speaker discloses any actual or potential conflict of interest.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).
Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.
Learning Outcome: After completing this learning activity, the participant will be able to describe new pharmacologic treatment available for cardiac patients.
Northeast Georgia Medical Center
You must be logged in and own this session in order to
3/3/21 1:59 pm
Wonderful overview of cardiology meds and disease processes that I encounter frequently as a PCP. Great disease review with balanced focus on new meds available today for treatment.
3/4/21 5:42 pm
Thank you for a great presentation! I manage mostly HF pts with other chronic comorbidities . It's great to know that the meds you talked about (Entresto, Jardiance) are starting to be prescribed by our cardiologists. By the way, ALOHA from Honolulu
3/5/21 9:58 am
Excellent review thank you
3/5/21 10:59 am
Thanks for the overview. I was not aware of all the new advances on the hyperlipidemia front! Very exciting!
J Dea Browning
3/6/21 4:32 pm
Thank you for an excellent presentation that I will review frequently in the near future.
3/6/21 5:29 pm
Your equanimity in the face of such complexities, especially during flute practice, is commendable. No doubt your patients ( and family) adore you and count on you! Thank you for this wonderful education.